Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

NCT01270503 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

538

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Disease

Interventions

BIOLOGICAL: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company